Literature DB >> 20789685

Comparison of Ampicillin and Tetracycline in Chronic Bronchitis.

F J Millard, J C Batten.   

Abstract

Entities:  

Year:  1963        PMID: 20789685      PMCID: PMC2123122          DOI: 10.1136/bmj.1.5331.644

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  19 in total

1.  Long-term treatment of bronchlectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture.

Authors:  N S CHERNIACK; K L VOSTI; H F DOWLING; M H LEPPER; G G JACKSON
Journal:  AMA Arch Intern Med       Date:  1959-03

2.  Long-term prophylactic administration of tetracycline to chronic bronchitics.

Authors:  J BUCHANAN; W W BUCHANAN; A G MELROSE; J B McGUINNESS; A U PRICE
Journal:  Lancet       Date:  1958-10-04       Impact factor: 79.321

3.  Adult chronic bronchitis: continuous antibiotic therapy.

Authors:  G EDWARDS; E C FEAR
Journal:  Br Med J       Date:  1958-10-25

4.  Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis.

Authors:  P C ELMES; C M FLETCHER; A A DUTTON
Journal:  Br Med J       Date:  1957-11-30

5.  Adult chronic bronchitis; the infective factor and its treatment.

Authors:  G EDWARDS; A R BUCKLEY; E C FEAR; G M WILLIAMSON; K ZINNEMANN
Journal:  Br Med J       Date:  1957-08-03

6.  Long-continued treatment with tetracycline and prednisolone in chronic bronchitis; a controlled trial.

Authors:  E N MOYES; R A KERSHAW
Journal:  Lancet       Date:  1957-12-14       Impact factor: 79.321

7.  Bacteriology of bronchitis.

Authors:  J MULDER
Journal:  Proc R Soc Med       Date:  1956-10

8.  Pathogenic bacteria in chronic bronchitis.

Authors:  J R MAY
Journal:  Lancet       Date:  1954-10-23       Impact factor: 79.321

9.  Antibiotic prophylaxis in chronic respiratory diseases.

Authors:  L V McVAY; D H SPRUNT
Journal:  AMA Arch Intern Med       Date:  1953-12

10.  Long-term oxytetracycline (terramycin) therapy in advanced chronic respiratory infections.

Authors:  W H HELM; J R MAY; J L LIVINGSTONE
Journal:  Lancet       Date:  1954-09-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.